Usefulness of C 2 HEST Score in Predicting Clinical Outcomes of COVID-19 in Heart Failure and Non-Heart-Failure Cohorts.
Piotr RolaAdrian DoroszkoMałgorzata TrochaKatarzyna GiniewiczKrzysztof KujawaJakub GawryśTomasz MatysDamian GajeckiMarcin MadziarskiStanisław ZielińskiTomasz SkalecJarosław DrobnikAgata SebastianAnna Zubkiewicz-ZarębskaBarbara AdamikKrzysztof KaliszewskiKatarzyna Kiliś-PstrusinskaAgnieszka Matera-WitkiewiczMichał PomorskiMarcin ProtasiewiczJanusz SokołowskiSzymon WłodarczakEwa Anita JankowskaKatarzyna MadziarskaPublished in: Journal of clinical medicine (2022)
HEST score in the non-HF cohort showed significantly better performance in terms of predicting in-hospital and 6-month mortality and other non-fatal clinical outcomes such as cardiovascular events (myocardial injury, acute heart failure, myocardial infarction, cardiogenic shock), pneumonia, sepsis, and acute renal injury.
Keyphrases
- acute heart failure
- cardiovascular events
- heart failure
- coronary artery disease
- cardiovascular disease
- respiratory failure
- coronavirus disease
- sars cov
- left ventricular
- liver failure
- cardiac resynchronization therapy
- intensive care unit
- acute kidney injury
- healthcare
- atrial fibrillation
- drug induced
- adverse drug
- septic shock
- aortic dissection
- emergency department
- acute care
- risk factors
- acute respiratory distress syndrome